Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Obesity-related conditions

GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review

McCann C, Clement N, Murray A, Kearney R, Madigan S, Gee C, Walmsley P, Morrison S, Chopra S, Hall A. GLP-1 receptor agonists and weight-loss strategies for individuals with obesity and hip or knee osteoarthritis: a scoping review Br J Sports Med

How does survodutide work? Plain language review of a potential new medication for obesity and liver disease

Almandoz JP, Miras AD, Seufert J, Paul E. How does survodutide work? Plain language review of a potential new medication for obesity and liver disease Ther Adv Gastroenterol
MASLD

Pain in People Living With Obesity: Baseline Multidimensional Profiles, Prevalence and Biopsychosocial Factors From a Cohort Study

Hinwood NS, Dunlevy CG, Doody C, Blake C, Fullen BM, O Donoghue G, O Connell J, Le Roux CW, Finucane FM, Birney S, Fildes F, Smart KM. Pain in People Living With Obesity: Baseline Multidimensional Profiles, Prevalence and Biopsychosocial Factors From a Cohort Study Eur J Pain

Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Thyroid Function Tests: A Systematic Review Identifying a Critical Evidence Gap

Salama S, Elfaki Omer EO, Mahmoud A, Mohamed ElshikhIdris MA, Mahadi Hussien TM, Ahmed M, Fadulelsayed SO, Mohammed Ibrahim SA, Ali Mohammed HO, Alhajri AHM. Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Thyroid Function Tests: A Systematic Review Identifying a Critical Evidence Gap Int J Cardiol

Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis

Ateiwi YA, Mahmood R, Wong HJ, Low CE, Yau CE, Lee ARYB, Eng PC, Lee M, Chan MY, Sia CH. Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis Diabetes Res Clin Pract

Type 1 Diabetes Is a Barrier to Obesity Treatment: Patient Insights From a Mixed-Methods Study

Al Ozairi E, Alsaeed D, Mondoh A, Taghadom E, Irshad M, Alroudhan D, Kandari JA, Al-Najim W, le Roux CW. Type 1 Diabetes Is a Barrier to Obesity Treatment: Patient Insights From a Mixed-Methods Study J Obes
Insulin Resistance & Diabetes

“It Is a Vicious Circle”: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES)

Hinwood NS, Casey MB, Dunlevy CG, Doody C, Blake C, Fullen BM, O'Donoghue G, Birney S, Fildes F, Smart KM. “It Is a Vicious Circle”: Experiences of People Living With Obesity and Chronic Pain: A Qualitative Evidence Synthesis (QES) Obes Rev

Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes

Wharton S, le Roux CW, Bozkurt B, Platz E, Bleckert G, Ajaz Hussain S, Brueckmann M, Startseva E, Kloer IM, Kaplan LM. Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes Diabetes Obes Metab

Obesity and physical activity in children with early vision problems: a secondary analysis of data from the Growing-Up in Ireland study

Drews-Botsch C, Harrington S. Obesity and physical activity in children with early vision problems: a secondary analysis of data from the Growing-Up in Ireland study BMC Pediatr

Metabolic Health Phenotypes Among Middle- to Older-Aged Adults Living With and Without Obesity: Relationships With Hepatic Health Indicators

Dolan G, Millar SR, Perry IJ, Phillips CM. Metabolic Health Phenotypes Among Middle- to Older-Aged Adults Living With and Without Obesity: Relationships With Hepatic Health Indicators Hepatol Res
Genetics

Older posts

Page1 Page2 … Page25 Next →

Search for:

Recent Posts

10th ASOI Annual Scientific Meeting 2026
9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI